Dosing begins in Phase I trial of Medicago’s Covid-19 vaccine
Preliminary safety and immunogenicity data for the vaccine candidate are expected in October this year. Credit: HeungSoon from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more